Hematology/Oncology Consultations - ALGH

PREREQUISITES AND PLACEMENT IN THE CURRICULUM: Students must have completed the Medicine Core Clerkship; and have consent of the instructor.
PURPOSE: The course objectives are to provide a basic fund of knowledge in the following:
1) The process of malignant transformation;
2) The normal physiology of the bone marrow and blood clotting;
3) The pathophysiology of hematologic disease and coagulopathy;
4) The process of sequential staging of cancer;
5) The essentials of treatment.
This is a four-week course in which students gain experience in hematology/oncology consultation performed in the inpatient and outpatient settings. There is emphasis on patient evaluation, pathophysiology of hematologic disorders and malignancies, appropriate diagnostic studies, and treatment. Daily consultation rounds with an instructor on an inpatient and outpatient service. The objectives will be met by case presentations and didactic discussions. The reading materials to be used include a syllabus, handouts, important peer reviewed journal articles, and texts. The number of patients seen on a weekly basis will be 15-20 and the majority will be seen in the ambulatory setting. Students will have the opportunity to follow patients and will participate in didactic teaching, conferences, and reading of bone marrows.
ASSESSMENT: The evaluation of students will be carried out by instructors quizzing students. Students will be required to present a topic in depth.
Program Number: ELEC 804 Location: ALGH  
Program Director: J.Bitran, MD,  N. Kriaras (Coordinator), Vehida Spiodic
Telephone: 847-268-8200, 847-723-6464
E-Mail: Nicoletta.Kriaras@advocatehealth.com, Vehida.Spiodic@advocatehealth.com
Night Call:
Number of Students Accepted:
Housestaff Used as Faculty:
Lectures/ Conferences/ Faculty Contact:
Laboratory/Independent Study:

Total Hours/Week:

Reporting Instructions:

All M3s and M4s report to the Medical Student Office on their first day. M3s and M4s report on Monday (M3s at 8:00 AM) and (M4s at 8:30 AM).